REQUEST A DEMO
Total
USD $0.00
Search more companies

New Journey Health Technology Group Co.,Ltd (China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: New Journey Health Technology Group Co.,Ltd Profile Updated: November 24, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Gansu Duyiwei Biological Pharmaceutical Co., Ltd. wasfounded in September 30, 2001.The core product of the company is Tiber medicine Duyiweicapsule and created hundred million dollars sales volume ayear; has became the analgesia to stop bleeding one ofnatural prescription medicine domain leadership brands.The national Chinese medicine output value is RMB 47,661million in the domestic market in January to May 2007; theChinese native medicine has the widely market developmentspace and the potential, therefore by its unique curativeeffect and the security, the market prospect is well.

Headquarters
28th Floor, Fortune Financial Center, No. 5 East Third Ring Middle Road, Chaoyang District, Beijing
Chaoyang; Liaoning; Postal Code: 100020

Contact Details: Purchase the New Journey Health Technology Group Co.,Ltd report to view the information.

Website: http://www.njhtg.com

Basic Information
Total Employees:
Purchase the New Journey Health Technology Group Co.,Ltd report to view the information.
Outstanding Shares:
Purchase the New Journey Health Technology Group Co.,Ltd report to view the information.
Registered Capital:
Purchase the New Journey Health Technology Group Co.,Ltd report to view the information.
Financial Auditors:
Purchase the New Journey Health Technology Group Co.,Ltd report to view the information.
Incorporation Date:
September 30, 2001
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
24.23%
Purchase this report to view the information.
10.75%
Purchase this report to view the information.
5.61%
Purchase this report to view the information.
2.93%
Purchase this report to view the information.
2.17%
Subsidiaries
Chongqing Duyiwei Biopharmaceutical Co., Ltd.
100%
Chongzhou Hengde Hospital Co., Ltd.
100%
Chongzhou Lingcheng Hospital Co., Ltd
100%
Company Performance
Financial values in the chart are available after New Journey Health Technology Group Co.,Ltd report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
6.93%
Total operating revenue
7.02%
Operating profit (EBIT)
81.87%
Net Profit (Loss) for the Period
55.92%
Total assets
0.36%
Total equity
9.24%
Operating Profit Margin (ROS)
1.16%
Net Profit Margin
0.66%
Return on Equity (ROE)
0.72%
Debt to Equity Ratio
-16.67%
Quick Ratio
-0.03%
Cash Ratio
-0.05%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?